Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -0.44% is 110% below its 5-year average of 4.22%, near the high end of its 5-year range (-116.47%–13.30%).
98.14% above its 12-month average of -23.66%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.07%.
NET PROFIT MARGIN
-0.44%
NET PROFIT MARGIN AVG TTM
-23.66%
NET PROFIT MARGIN AVG 3Y
0.04%
NET PROFIT MARGIN AVG 5Y
4.22%
NET PROFIT MARGIN AVG 10Y
4.66%
NET PROFIT MARGIN AVG 15Y
4.31%
NET PROFIT MARGIN AVG 20Y
5.15%
CURRENT VS TTM AVG
+98.14%
CURRENT VS 3Y AVG
-1236.02%
CURRENT VS 5Y AVG
-110.42%
CURRENT VS 10Y AVG
-109.44%
CURRENT VS 15Y AVG
-110.21%
CURRENT VS 20Y AVG
-108.55%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 721 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Integra LifeSciences Holdings Corporation
Market Cap
$1.03B
Net Profit Margin
-0.44%
TTM Avg
-23.66%
3Y Avg
0.04%
5Y Avg
4.22%
Market Cap
$1.04B
Net Profit Margin
-5.43%
TTM Avg
-0.76%
3Y Avg
-19.17%
5Y Avg
-21.06%
Market Cap
$1.04B
Net Profit Margin
-493.26%
TTM Avg
-198.62%
3Y Avg
-139.13%
5Y Avg
-250.17%
Market Cap
$1.04B
Net Profit Margin
-321.81%
TTM Avg
-893.93%
3Y Avg
-810.32%
5Y Avg
-689.93%
Market Cap
$1.02B
Net Profit Margin
-2.66%
TTM Avg
-7.26%
3Y Avg
-9.19%
5Y Avg
-9.19%
Market Cap
$1.05B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$1.01B
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$996.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.06B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-57.69%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corporation (IART) | $1.03B | -0.44% | -23.66% | 0.04% | 4.22% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -5.43% | -0.76% | -19.17% | -21.06% |
| Immatics N.V. (IMTX)vs › | $1.04B | -493.26% | -198.62% | -139.13% | -250.17% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | -321.81% | -893.93% | -810.32% | -689.93% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -2.66% | -7.26% | -9.19% | -9.19% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.13% | -23.45% | -155.72% | -114.72% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $996.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.06B | 0.00% | 0.00% | 0.00% | -57.69% |
| MeiraGTx Holdings plc (MGTX)vs › | $992.02M | 19.87% | -292.21% | -499.51% | -430.28% |
Operating Margin
4.2%
Net Profit Margin
-0.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 1.07% |
| 2026-03-31 | -1.18% |
| 2025-12-31 | -0.39% |
| 2025-09-30 | -1.34% |
| 2025-06-30 | -116.47% |
| 2025-03-31 | -6.61% |
| 2024-12-31 | 4.39% |
| 2024-09-30 | -2.81% |
| 2024-06-30 | -2.97% |
| 2024-03-31 | -0.89% |
| 2023-12-31 | 5.00% |
| 2023-09-30 | 5.10% |
| 2023-06-30 | 1.10% |
| 2023-03-31 | 6.36% |
| 2022-12-31 | 13.30% |
| 2022-09-30 | 12.96% |
| 2022-06-30 | 11.26% |
| 2022-03-31 | 8.74% |
| 2021-12-31 | 11.19% |
| 2021-09-30 | 11.17% |
| 2021-06-30 | 8.99% |
| 2021-03-31 | 12.61% |
| 2020-12-31 | 23.86% |
| 2020-09-30 | 8.73% |
| 2020-06-30 | -0.14% |
| 2020-03-31 | 2.59% |
| 2019-12-31 | 3.88% |
| 2019-09-30 | -7.28% |
| 2019-06-30 | 7.75% |
| 2019-03-31 | 9.11% |
| 2018-12-31 | 6.56% |
| 2018-09-30 | 3.63% |
| 2018-06-30 | 3.11% |
| 2018-03-31 | 3.08% |
| 2017-12-31 | 12.03% |
| 2017-09-30 | 1.13% |
| 2017-06-30 | 3.84% |
| 2017-03-31 | 2.47% |
| 2016-12-31 | 11.05% |
| 2016-09-30 | 8.05% |
| 2016-06-30 | 5.12% |
| 2016-03-31 | 4.92% |
| 2015-12-31 | 6.21% |
| 2015-09-30 | -14.08% |
| 2015-06-30 | 2.05% |
| 2015-03-31 | 3.59% |
| 2014-12-31 | 6.81% |
| 2014-09-30 | 4.27% |
| 2014-06-30 | 2.09% |
| 2014-03-31 | 1.03% |
| 2013-12-31 | 5.52% |
| 2013-09-30 | -13.39% |
| 2013-06-30 | 1.67% |
| 2013-03-31 | -2.06% |
| 2012-12-31 | 5.96% |
| 2012-09-30 | 6.29% |
| 2012-06-30 | 4.05% |
| 2012-03-31 | 3.41% |
| 2011-12-31 | 2.24% |
| 2011-09-30 | 5.56% |
| 2011-06-30 | 0.36% |
| 2011-03-31 | 6.34% |
| 2010-12-31 | 9.69% |
| 2010-09-30 | 8.83% |
| 2010-06-30 | 8.49% |
| 2010-03-31 | 8.81% |
| 2009-12-31 | 8.57% |
| 2009-09-30 | 8.38% |
| 2009-06-30 | 6.77% |
| 2009-03-31 | 5.94% |
| 2008-12-31 | 14.25% |
| 2008-09-30 | -9.15% |
| 2008-06-30 | 8.79% |
| 2008-03-31 | 7.41% |
| 2007-12-31 | 3.41% |
| 2007-09-30 | 7.16% |
| 2007-06-30 | 6.93% |
| 2007-03-31 | 7.38% |
| 2006-12-31 | 8.08% |
| 2006-09-30 | 2.22% |
| 2006-06-30 | 7.97% |
| 2006-03-31 | 11.29% |
| 2005-12-31 | 14.54% |
| 2005-09-30 | 15.12% |
| 2005-06-30 | 10.97% |
| 2005-03-31 | 12.82% |
| 2004-12-31 | 15.92% |
| 2004-09-30 | -12.85% |
| 2004-06-30 | 13.32% |
| 2004-03-31 | 14.18% |
| 2003-12-31 | 15.54% |
| 2003-09-30 | 14.52% |
| 2003-06-30 | 12.68% |
| 2003-03-31 | 14.79% |
| 2002-12-31 | 84.40% |
| 2002-09-30 | 5.17% |
